Listed below are some of the biotech stocks that have shown notable activity in pre-market trading Tuesday, as of 8.15 a.m. ET.
In the Green
CNS Pharmaceuticals, Inc. (CNSP) is up over 103% at $2.46.Xilio Therapeutics, Inc. (XLO) is up over 28% at $0.94.OptimizeRx Corporation (OPRX) is up over 23% at $11.39.Alzamend Neuro, Inc. (ALZN) is up over 24% at $6.40.Enanta Pharmaceuticals, Inc. (ENTA) is up over 11% at $6.20.Neumora Therapeutics, Inc. (NMRA) is up over 11% at $0.77.Medicus Pharma Ltd. (MDCX)is up over 11% at $5.40.Black Diamond Therapeutics, Inc. (BDTX) is up over 9% at $1.92.Cyclacel Pharmaceuticals, Inc. (CYCC) is up over 9% at $3.93.Dyne Therapeutics, Inc. (DYN) is up over 7% at $13.50.Ainos, Inc. (AIMD) is up over 7% at $0.59.Arrowhead Pharmaceuticals, Inc. (ARWR) is up over 8% at $15.12.REGENXBIO Inc. (RGNX)is up over 7% at $8.56.Universe Pharmaceuticals INC (UPC) is up over 6% at $4.73.Leap Therapeutics, Inc. (LPTX) is up over 6% at $0.40.UroGen Pharma Ltd. (URGN) is up over 6% at $11.88.Protagenic Therapeutics, Inc. (PTIX) is up over 6% at $3.26.Cellectar Biosciences, Inc. (CLRB) is up over 5% at $0.28.Psyence Biomedical Ltd. (PBM)is up over 5% at $3.88.Anixa Biosciences, Inc. (ANIX) is up over 5% at $2.80.Werewolf Therapeutics Inc (HOWL) is up over 5% at $1.05.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.